[Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma]

MeSH terms

• Adolescent
• Adult
• Aged
• Agranulocytosis / chemically induced
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Cisplatin / administration & dosage
• Cisplatin / adverse effects
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / adverse effects
• Doxorubicin / administration & dosage*
• Doxorubicin / adverse effects
• Etoposide / administration & dosage*
• Etoposide / adverse effects
• Female
• Follow-Up Studies
• Humans
• Lymphoma, T-Cell, Peripheral / drug therapy*
• Male
• Middle Aged
• Nausea / chemically induced
• Prednisone / administration & dosage
• Prednisone / adverse effects
• Remission Induction
• Vincristine / administration & dosage
• Vincristine / adverse effects
• Young Adult